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ABSTRACT The cardio protective functions of HDL are attributed to the HDL-associated proteins like Paraoxonase
1 (PON1). PON1 is associated with HDL through a N-terminal signal peptide.  HDL-associated PON1 alone is
cardio protective. Indians have normal HDL levels and yet a high risk of cardiovascular diseases. Hence, the
presence of polymorphisms in the promoter region and first exon of PON1 were investigated in 256 individuals to
find out whether the polymorphisms could be the cause of the high risk. Out of these 256 individuals,  195 were
from Vokkaliga community and the rest were from other communities. Whole blood was collected, plasma and cells
were separated. Plasma was used for determination of PON1 activity and for lipid analysis.  Cells were used for DNA
extraction.DNA was sequenced from -1246 to +203 of the PON1 gene. Nine single nucleotide polymorphisms(SNPs)
were identified of which three were new SNPs, two of which were in the 5’ flanking region of the putative mRNA
for the protein but none in the first exon. Our results show that the low active PON1 phenotype was predominant
in the Vokkaliga population.
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Cardiovascular diseases (CVD) are the leading
cause of death for men and women among all racial
and ethnic groups (Pyrola  et al. 1987). Diverse
studies have established the role of many risk
factors for atherosclerosis and the only negative
risk factor was found to be High Density
Lipoprotein (HDL) measured as HDL-cholesterol
(Tan  1980).  It is now established that the cardiopro-
tective function of HDL is due to the presence of
various enzymes and proteins associated with  the
HDL particle. The antioxidant enzyme of HDL
extensively characterized in recent years is
paraoxonase.
Paraoxonase (EC 3.1.8.1) is a 43 KDa protein
coded by the PON1 gene containing 9 exons and
encoding a 354 aminoacid glycosylated peptide.
It is located on the long arm of choromosome 7 (q
21.3 - q22.1) along with the other members of the
gene family, namely, PON2 and PON3 (Primo-
Parmo  et al. 1996 ; Durrington  et al. 2001).
Polymorphic forms of PON1 protein were reported
with widely differing substrate specificities and
specific activities. The two important polymorphic
forms are L55M and Q192R. The Q192R poly-
morphism causes substrate dependent differe-
nces in the kinetics of hydrolysis.  Arginine at
192 specifies high PON activity whereas
glutamine specifies low PON activity.  In L55M
polymorphism, Leucine at 55 is correlated with
higher PON1 activity and mRNA levels than
Methionine (Brophy  et al. 2001).
In addition to the polymorphisms in the coding
region, PON1 has six single nucleotide
polymorphisms (SNPs) in the  promoter region.
They are– -108 , -126, -162, -832 , -909  and -1076
(Brophy  et al. 2001a ; Brophy  et al. 2001b).  Since
promoters are important cis acting elements,
promoter variants may also alter gene expression.
(Hoogendoorn  et al. 2003). In our previous
studies we found that the distribution of PON1
activity in south Indians was negatively skewed
and showed a large standard deviation (Mahade-
shprasad  et al  2010). We also found that PON1
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was not completely associated with HDL
(Jaichander  2006). Since PON1-HDL association
is essential for its cardioprotective function, and
since PON1-HDL association is through the N-
terminal hydrophobic peptide of PON1 (Sorenson
et al. 1999), in this study we investigated possible
SNPs in the promoter region and the first exon
which would affect the amount of PON and its
association   with HDL.
We have chosen members of the Vokkaliga
community for our study since they represent an
endogamous group where cross cousin marriages
are allowed.  They are mostly non-vegetarians.
Cultivation is their main occupation as indicated
by their name ‘vokku’,  meaning ‘to thresh grain’
They are found scattered in almost all parts of the
Karnataka State, India (Prabhakar  and  Gangadhar
2009)  and account for about 15% of the total
population.
In our study sample, we report the presence
of nine SNPs  in the promoter region, with three
novel SNPs.  Out of these, two were found
exclusively in Vokkaliga population and one
exclusively in the others.
MATERIALS  AND  METHODS
Chemicals and reagents used were from Sigma
Aldrich, USA. The sequencing chemicals were from
Applied Biosystems. The primers 5’agctgaccac-
tttccctctc3’;   5’agcactcactttgtgccatc3’ and 5’aggaa-
atgaatgagctgtgtg3’; 5’agagtgtgca-tctagca-cctg 3’
were from Sigma Genosys.
Sample Collection: Whole  blood was taken
from subjects from Gollanabeedu and Saragur
villages of HD Kote Taluk , Mysore District,
Karnataka, India. The study sample comprised of
a total of 256 individuals (195 belonged to
Vokkaliga community and 61 belonged to other
communities). Ethical clearance for this study was
obtained from the Institutional Human Ethical
committee, University of Mysore, Mysore.
Informed consent was obtained from each subject
before taking the blood sample.
Enzyme Activity: PON1 enzyme activity was
determined spectrophotometrically using phenyl
acetate as substrate (Eckerson et al.1983). One
unit of PON1 activity was defined as 1 micromole
of phenyl acetate hydrolyzed per min.
Lipid Analysis:  Total cholesterol and trigly-
ceride were estimated by enzymatic methods using
diagnostic kits (Accurex Biomedical) (Goswami
and Bandyopadhyay  2003).
DNA Extraction and Sequencing: DNA was
extracted using phenol: chloroform method
(Sambrook et al. 1989).
DNA Extraction:  Briefly the cells are lysed in
an alkaline lysis buffer.  The lysate was incubated
at 56oC in the presence of Proteinase K and SDS
to partially digest cellular proteins and loosen the
association between proteins and chromosomal
DNA. The cell lysate was then treated with buffer-
saturated phenol:chloroform . The DNA remains
in the aqueous phase while the cellular proteins
are extracted into the organic phase. The aqueous
phase was extracted a second time with phenol:
chloroform to ensure complete removal of the
proteins.  The aqueous phase, containing the DNA
was then treated with isopropanol to precipitate
the DNA. The DNA was washed with chilled
ethanol and then dissolved in TE Buffer (10 mM
Tris-HCl, 1mM EDTA, pH 8.0). DNA extracted this
way was generated as high molecular weight
(average fragment size>20kb) and double
stranded.   The DNA quality  was assessed by the
ratio of absorption at 260nm and 280nm . Ratio of
1.6 to 2.0 was used as an indicator of DNA free
from contamination.
 Prior to PCR amplification, DNA samples were
checked for purity and integrity. Electrophoretic
analysis of DNA using agarose gels was used to
confirm  integrity of DNA.  DNA  fragments were
visualized under UV light by staining with ethidium
bromide. The final concentration of DNA used in
PCR amplification was decided based on the
preliminary gel electrophoretic scan. Contaminated
or sheared samples were discarded.
PCR and DNA Sequencing: The DNA
sequence from -1246 to +203 was amplified using
primers which cover both promoter region and
first exon of PON1 gene. Cycling conditions were
as follows: 94oC for 3 minutes for initial de-
naturation followed by 35 cycles of following
conditions.  94oC for one minute, 56oC for 45
seconds and 72oC for 2.5 minutes and final
extension for 7 minutes at 72oC. PCR product was
used to perform cycle sequencing reaction with
ABI Prism BigDye™ v 3.1 as per the instructions
provided by the manufactures of the kits. After
cleanup, the cycle sequencing product was run
on an ABI 3730 DNA Analyzer to get the sequence
of the amplified region.
DNA Sequencing: Sequencing was carried out
using Applied Biosystems 3730 genetic analyzer
with a 48 capillary system.  During the sequencing
run, the labeled DNA fragments migrate through
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the gel according to their size and a laser is used to
excite the fluorescently labeled fragments as they
pass the laser window.  Fluorescence is detected,
data collected, processed and interpreted by a
computer. The final output is a colour profile
(chromatogram), which displays peaks and
corresponding base calls. All the samples were
sequenced and data analysed statistically
Statistical Analysis: Statistical analysis was
carried out using SNP associated R package-
software and SPSS v12.
RESULTS  AND  DISCUSSION
The main objective of this study was to look
for the presence of novel polymorphisms in the
promoter region and first exon of PON1 gene and
hence, a non- random sample was selected for the
study. In this sample we also found members of
the other communities and they constitute the
accidental sample. A total of 16 communities are
represented in this accidental sample. The number
of individuals in each of these groups varied  from
1 to a maximum of 18.   Biochemical characteristics
of the subjects are presented in Table 1. All the
parameters studied had similar distribution in the
Table 1: Biochemical Characteristics of Vokkaliga and
Non-Vokkaliga population
S . Parameters   Vokkaliga                 Others
No.                  (Mean±SD)            (Mean ±SD)
1 Cystolic blood 121.89 ± 9.48   127.16 ±  15.74
pressure
2 Diastolic   79.85 ± 5.16    80.69 ±  7.54
blo od
pressure
3 BMI   21.63 ± 3.66    23.59 ±  3.68
4 WH R     0.91± 0.06     0.94 ±  0.11
5 PON1        19279.91 ±18782.67  27500.15 ± 20743.30
activity
6 Total 170.67 ± 27.22  172.65 ± 34.01
cholesterol
7 Triglycerides    151.35 ± 77.74  157.26 ± 65.10
8 HDL                44.09 ± 4.08    43.17 ± 4.73
9 LDL                96.28 ± 21.07    97.94 ± 28.69
BMI – Body Mass Index; WHR – Waist Hip Ratio; HDL
– High Density Lipoprotein;
LDL – Low Density Lipoprotein
two study groups namely the Vokkaligas and
Others (non-Vokkaligas) with no significant
differences between them  except PON1 activity
showed a significant difference (P<0.05). PON1
activity was lower in Vokkaliga population
compared with others.  Since the sample was a
non- probability sample and one of the groups
was an accidental sample, the difference in PON1
activity between Vokkaligas and others may be an
artifact. However, the large sample variations both
in Vokkaligas and others was seen which was
consistent with our earlier observation.
The results of genotype and allele frequencies
are presented in Table 2.  A total of nine SNPs
were detected. Six of these were already known
polymorphisms.  Three SNPs, namely,  -725, -283
and -165 were novel  Out of the three novel
polymorphisms two  (-725 and -283) were found
exclusively in Vokkaliga population and one (-165)
exclusively in non-Vokkaligas. It is possible  that
there are other polymorphisms but with lesser
frequency.  In order to study this, a  larger sample
would be required for the study. Novel
polymorphism (-165) found exclusively in the other
group is possibly an accidental finding.  There
was only one representative from Vishwakarma
community and he had this polymorphism. To
know the frequency of these polymorphisms larger
sample size is required. However, the three novel
polymorphisms identified in our study are
completely new and have not been reported in
literature so far. Also, the chances of accumulating
polymorphism, if any would be high in Vokkaliga
community compared with others in this region,
since Vokkaligas are an endogamous group.
In our study, the PON1 activity was found to
be lower in Vokkaliga population when compared
with others. This was consistent with the
observation that in the exclusive polymorphism
of the -725 SNP, the AA genotype was associated
with low PON1 activity whereas the AG genotype
was associated with high PON1 activity.  However,
the frequency of the high PON1 active AG
genotype was very small (0.0044) suggesting that
the genotype for low PON1 activity is highly
prevalent among Vokkaligas.
A study of the human promoter polymor-
phisms of a variety of genes has shown that they
may modify gene expression by as much as  50%
or more (Voetsch  et al. 2007).   Since the -725 SNP
is in the 5’ flanking region, whether it is the cause
of low level of transcription, is not known.
In our study, polymorphism beyond -108 upto
+203 was not observed.  This region would have
the N-terminal signal sequence. Since no polymor-
phism was observed in this region, it is unlikely
that lack of association of PON1 with HDL may be
the cause of low cardio protection.
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